Client News

NOXXON presents updated results from Phase 1/2 NOX-A12 / Keytruda combination trial at AACR 2019

InflaRx Full Year 2018 Financial & Operating Results

Probiodrug reports full year 2018 financial results

Heidelberg Pharma to present its proprietary ATAC technology platform at the AACR Annual Meeting 2019

Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome

Motif Bio plc: Proposed Equity Fundraise

Adrenomed’s Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II

MagForce AG successfully completes installation of mobile NanoTherm treatment center for brain tumors in Poland

Breath Therapeutics Announces Presentations at Upcoming Scientific Conferences

Topas Therapeutics to Participate at Upcoming Industry and Scientific Conferences